We are live on ! Find out more
AH

Accretive Health
AH

Delisted

AH was delisted on the 14th of March, 2014.

6 hedge funds and large institutions have $23.4M invested in Accretive Health in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $17.7M → $23.4M (+$5.75M)

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AH Hedge Fund Activity: Q2 2015 in Review

6 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q2 2015, worth a combined $23.4M — up 33% from $17.7M a quarter earlier.

Fund positioning in AH was balanced in Q2 2015: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was GMT Capital, opening a new position worth an estimated $4.09M. The largest seller was Northern Trust, exiting entirely with an estimated $111K sold.

  • 6 institutional investors held Accretive Health (AH) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $23.4M of Accretive Health stock for Q2 2015, up 33% quarter-over-quarter.
  • 1 fund opened new Accretive Health positions in Q2 2015 and 1 closed out, a net change of 0 holders.
  • The largest Accretive Health buyer in Q2 2015 was GMT Capital, an estimated $4.09M added.
  • The largest Accretive Health seller in Q2 2015 was Northern Trust, an estimated $111K sold.

Based on aggregated 13F filings for Q2 2015.